Dana Hawkinson is an Infectious Disease physician affiliated with University of Kansas. OpenAlex indexes 18 publications with 433 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20214 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Tetracycline-class Drug32.8%Doxycycline Hyclate79%Doxycycline Monohydrate21%Part D<11 patientsShort-acting sulfonamides24.3%Sulfamethoxazole-Trimethoprim100%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Erosion of a Pillar of Public Health: ACIP's Role and the Future of US Vaccine Policy Post-June 2025
Clinical Infectious Diseases
2026 - Myiasis as a Vector for Bacteremia: A Unique Case of Helcococcus kunzii and Ignatzschineria ureiclastica/larvae Polymicrobial Bacteremia from Myiasis
Vector-Borne and Zoonotic Diseases
2024 - ESKD and Incidence and Outcomes With COVID-19: A 2-Year Review in US Veterans
Journal of the American Society of Nephrology
2022 - PD63-09 IDENTIFICATION OF MICROBIAL COLONIZATION PATTERNS IN EXPLANTED ARTIFICIAL URINARY SPHINCTERS
The Journal of Urology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Gary Gronseth, MD
University of Kansas
Steven Simpson, MD
University of Kansas
Douglas Burton, MD
University of Kansas
Fen Wang, MD
University of Kansas
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”